These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 21716187)

  • 1. Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.
    Finocchietti M; Marino ML; Rosa AC; Bellini A; Masiero L; Cardillo M; Massari M; Spila Alegiani S; Pierobon S; Ferroni E; Zanforlini M; Leoni O; Ledda S; Garau D; Davoli M; Addis A; Belleudi V;
    Drug Des Devel Ther; 2024; 18():53-69. PubMed ID: 38229916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin.
    Riva N; Guido PC; Ibañez J; Licciardone N; Rousseau M; Mato G; Monteverde M; Schaiquevich P
    Int J Clin Pharm; 2014 Aug; 36(4):779-86. PubMed ID: 24861769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in abdominal organ transplantation.
    Kosieradzki M; Lisik W; Rowiński W; Małkowski P
    Med Sci Monit; 2011 Dec; 17(12):RA282-91. PubMed ID: 22129915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance immunosuppressive therapy and generic cyclosporine A use in adult renal transplantation: a single center analysis.
    Diarra DA; Riegersperger M; Säemann MD; Sunder-Plassmann G
    Kidney Int Suppl; 2010 Mar; (115):S8-11. PubMed ID: 20150906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial.
    Durlik M; Paczek L; Rutkowski B; Lewandowska D; Debska-Slizien A; Chamienia A; Wyzgal J; Ognista-Gajda A; Niemczyk M
    Ann Transplant; 2010; 15(3):51-9. PubMed ID: 20877267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to generic cyclosporine A in stable chronic patients after heart transplantation.
    Kraeuter M; Helmschrott M; Erbel C; Gleissner CA; Frankenstein L; Schmack B; Ruhparwar A; Ehlermann P; Katus HA; Doesch AO
    Drug Des Devel Ther; 2013; 7():1421-6. PubMed ID: 24348018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial.
    Vítko S; Ferkl M
    Kidney Int Suppl; 2010 Mar; (115):S12-6. PubMed ID: 20150905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of EQUORAL in de novo renal transplant recipients.
    Zadrazil J; Jabry SA; Bachleda P; Gibejová A
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Dec; 148(2):171-3. PubMed ID: 15744368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic formulation of Cyclosporine A, Equoral®, in de novo kidney transplant recipients: five-year follow-up.
    Niemczyk M; Paczek L
    Ann Transplant; 2011; 16(2):59-62. PubMed ID: 21716187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.
    Pollard S; Nashan B; Johnston A; Hoyer P; Belitsky P; Keown P; Helderman H;
    Clin Ther; 2003 Jun; 25(6):1654-69. PubMed ID: 12860490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
    Goring SM; Levy AR; Ghement I; Kalsekar A; Eyawo O; L'Italien GJ; Kasiske B
    Curr Med Res Opin; 2014 Aug; 30(8):1473-87. PubMed ID: 24628478
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.